vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and EASTERN CO (EML). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $55.3M, roughly 1.1× EASTERN CO). EASTERN CO runs the higher net margin — 1.0% vs -70.9%, a 72.0% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -22.4%). EASTERN CO produced more free cash flow last quarter ($3.1M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -0.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
CTKB vs EML — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $55.3M |
| Net Profit | $-44.1M | $578.9K |
| Gross Margin | 52.9% | 22.3% |
| Operating Margin | -9.0% | 3.1% |
| Net Margin | -70.9% | 1.0% |
| Revenue YoY | 8.1% | -22.4% |
| Net Profit YoY | -557.1% | 103.8% |
| EPS (diluted) | — | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | — | ||
| Q3 25 | $52.3M | $55.3M | ||
| Q2 25 | $45.6M | $70.2M | ||
| Q1 25 | $41.5M | $63.3M | ||
| Q4 24 | $57.5M | $64.3M | ||
| Q3 24 | $51.5M | $71.3M | ||
| Q2 24 | $46.6M | $72.6M | ||
| Q1 24 | $44.9M | $64.6M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $578.9K | ||
| Q2 25 | $-5.6M | $3.4M | ||
| Q1 25 | $-11.4M | $1.9M | ||
| Q4 24 | $9.6M | $1.3M | ||
| Q3 24 | $941.0K | $-15.3M | ||
| Q2 24 | $-10.4M | $3.5M | ||
| Q1 24 | $-6.2M | $1.9M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | 22.3% | ||
| Q2 25 | 52.3% | 23.3% | ||
| Q1 25 | 48.6% | 22.4% | ||
| Q4 24 | 58.5% | 23.6% | ||
| Q3 24 | 56.3% | 25.5% | ||
| Q2 24 | 54.6% | 25.4% | ||
| Q1 24 | 51.3% | 23.9% |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | 3.1% | ||
| Q2 25 | -23.3% | 4.5% | ||
| Q1 25 | -36.1% | 5.1% | ||
| Q4 24 | 5.2% | 6.1% | ||
| Q3 24 | -8.2% | 9.5% | ||
| Q2 24 | -18.3% | 8.3% | ||
| Q1 24 | -23.9% | 5.3% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 1.0% | ||
| Q2 25 | -12.2% | 4.9% | ||
| Q1 25 | -27.5% | 3.1% | ||
| Q4 24 | 16.8% | 2.0% | ||
| Q3 24 | 1.8% | -21.5% | ||
| Q2 24 | -22.4% | 4.8% | ||
| Q1 24 | -13.8% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.10 | ||
| Q2 25 | — | $0.56 | ||
| Q1 25 | — | $0.32 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $-2.46 | ||
| Q2 24 | — | $0.56 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $9.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $124.3M |
| Total Assets | $461.5M | $220.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | $9.2M | ||
| Q2 25 | $75.5M | $9.1M | ||
| Q1 25 | $95.3M | $10.2M | ||
| Q4 24 | $98.7M | $16.1M | ||
| Q3 24 | $162.3M | $9.7M | ||
| Q2 24 | $177.9M | $2.0M | ||
| Q1 24 | $168.8M | $2.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $42.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | — | ||
| Q3 25 | $378.6M | $124.3M | ||
| Q2 25 | $377.6M | $124.4M | ||
| Q1 25 | $379.6M | $121.0M | ||
| Q4 24 | $395.7M | $120.7M | ||
| Q3 24 | $385.5M | $119.2M | ||
| Q2 24 | $389.1M | $136.5M | ||
| Q1 24 | $392.6M | $134.5M |
| Q4 25 | $461.5M | — | ||
| Q3 25 | $494.9M | $220.0M | ||
| Q2 25 | $493.3M | $229.4M | ||
| Q1 25 | $482.6M | $232.3M | ||
| Q4 24 | $499.5M | $235.3M | ||
| Q3 24 | $491.2M | $244.2M | ||
| Q2 24 | $483.7M | $255.9M | ||
| Q1 24 | $492.1M | $253.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.35× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $3.1M |
| Free Cash FlowOCF − Capex | $-1.8M | $3.1M |
| FCF MarginFCF / Revenue | -2.9% | 5.5% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 5.38× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $12.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $3.1M | ||
| Q2 25 | $108.0K | $3.8M | ||
| Q1 25 | $-125.0K | $-1.8M | ||
| Q4 24 | $2.0M | $11.0M | ||
| Q3 24 | $13.2M | $-2.9M | ||
| Q2 24 | $6.2M | $8.4M | ||
| Q1 24 | $4.0M | $2.8M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $3.1M | ||
| Q2 25 | $-1.5M | $3.0M | ||
| Q1 25 | $-974.0K | $-2.7M | ||
| Q4 24 | $1.1M | $9.0M | ||
| Q3 24 | $12.2M | $-7.7M | ||
| Q2 24 | $5.2M | $7.3M | ||
| Q1 24 | $3.4M | $1.1M |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | 5.5% | ||
| Q2 25 | -3.2% | 4.3% | ||
| Q1 25 | -2.3% | -4.3% | ||
| Q4 24 | 1.9% | 13.9% | ||
| Q3 24 | 23.7% | -10.8% | ||
| Q2 24 | 11.0% | 10.1% | ||
| Q1 24 | 7.6% | 1.7% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 1.1% | ||
| Q1 25 | 2.0% | 1.3% | ||
| Q4 24 | 1.6% | 3.2% | ||
| Q3 24 | 2.0% | 6.7% | ||
| Q2 24 | 2.3% | 1.5% | ||
| Q1 24 | 1.3% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.38× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | -0.95× | ||
| Q4 24 | 0.21× | 8.41× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 2.40× | ||
| Q1 24 | — | 1.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
EML
Segment breakdown not available.
